John Steven

705 total citations
23 papers, 547 citations indexed

About

John Steven is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, John Steven has authored 23 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in John Steven's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Nanoparticle-Based Drug Delivery (3 papers) and T-cell and B-cell Immunology (3 papers). John Steven is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Nanoparticle-Based Drug Delivery (3 papers) and T-cell and B-cell Immunology (3 papers). John Steven collaborates with scholars based in United Kingdom, United States and Belgium. John Steven's co-authors include Caroline J. Barelle, A.J. Porter, Marina Kovaleva, Laura T. Ferguson, D. J. Ballance, A. R. Goodey, Mischa Müller, Kenneth Saunders, Graham Belfield and Darrell Sleep and has published in prestigious journals such as Nature Biotechnology, Cancer Research and Chemical Communications.

In The Last Decade

John Steven

23 papers receiving 521 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Steven 334 280 135 61 54 23 547
Gerald P. Donovan 322 1.0× 271 1.0× 235 1.7× 115 1.9× 30 0.6× 18 891
Andrea L. J. Marschall 402 1.2× 223 0.8× 189 1.4× 84 1.4× 40 0.7× 16 613
Susanne Kubetzko 297 0.9× 245 0.9× 90 0.7× 96 1.6× 38 0.7× 8 535
Mahdi Habibi‐Anbouhi 589 1.8× 452 1.6× 302 2.2× 181 3.0× 95 1.8× 68 975
Cécile Artaud 358 1.1× 88 0.3× 167 1.2× 55 0.9× 19 0.4× 19 590
Amélie Robert 443 1.3× 55 0.2× 76 0.6× 104 1.7× 28 0.5× 24 788
Tove Eriksson 404 1.2× 556 2.0× 71 0.5× 228 3.7× 67 1.2× 12 918
C. R. Bebbington 748 2.2× 374 1.3× 239 1.8× 120 2.0× 27 0.5× 16 1.0k
Teodor‐D. Brumeanu 227 0.7× 149 0.5× 379 2.8× 85 1.4× 39 0.7× 35 718
Karen Silence 523 1.6× 654 2.3× 281 2.1× 103 1.7× 38 0.7× 6 884

Countries citing papers authored by John Steven

Since Specialization
Citations

This map shows the geographic impact of John Steven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Steven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Steven more than expected).

Fields of papers citing papers by John Steven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Steven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Steven. The network helps show where John Steven may publish in the future.

Co-authorship network of co-authors of John Steven

This figure shows the co-authorship network connecting the top 25 collaborators of John Steven. A scholar is included among the top collaborators of John Steven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Steven. John Steven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steven, John, P. P. A. Smyth, A.J. Porter, et al.. (2023). Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugation. Journal of Materials Chemistry B. 11(19). 4181–4190. 4 indexed citations
2.
Smyth, Peter, Laura T. Ferguson, John Steven, et al.. (2020). Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature. Nanoscale. 12(27). 14751–14763. 18 indexed citations
3.
4.
Pepple, Kathryn L., Leslie Wilson, Russell N. Van Gelder, et al.. (2019). Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand. Translational Vision Science & Technology. 8(5). 11–11. 6 indexed citations
5.
Cotton, Graham, Stacey J. Bell, Mark Wappett, et al.. (2019). Abstract 222: Novel protein drug conjugates targeting ROR1 through the development and exploitation of a drug discovery platform based on small, engineered VNAR domains. Cancer Research. 79(13_Supplement). 222–222. 3 indexed citations
6.
Ferguson, Laura T., et al.. (2018). Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability. Biochemical Society Transactions. 46(6). 1559–1565. 34 indexed citations
7.
Kovaleva, Marina, Jiquan Zhang, John Steven, et al.. (2018). Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. Journal of Immunology Research. 2018. 1–13. 11 indexed citations
8.
9.
Steven, John, Mischa Müller, Miguel F. Carvalho, et al.. (2017). In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development. Frontiers in Immunology. 8. 1361–1361. 36 indexed citations
10.
Kovaleva, Marina, Katherine Johnson, John Steven, Caroline J. Barelle, & A.J. Porter. (2017). Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis. Frontiers in Immunology. 8. 37 indexed citations
11.
Kovaleva, Marina, Laura T. Ferguson, John Steven, A.J. Porter, & Caroline J. Barelle. (2014). Shark variable new antigen receptor biologics – a novel technology platform for therapeutic drug development. Expert Opinion on Biological Therapy. 14(10). 1527–1539. 70 indexed citations
12.
Müller, Mischa, Kenneth Saunders, Christopher Grace, et al.. (2012). Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain. mAbs. 4(6). 673–685. 73 indexed citations
13.
Crouch, Kathryn, Wei Cao, Mischa Müller, et al.. (2011). Characterization of the immunoglobulin repertoire of the spiny dogfish (Squalus acanthias). Developmental & Comparative Immunology. 36(4). 665–679. 34 indexed citations
14.
Goodchild, Sarah A., Lyn M. O’Brien, John Steven, et al.. (2011). A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus. Antiviral Research. 90(1). 1–8. 19 indexed citations
15.
Steven, John, Douglas GJ McKechnie, & Alexander Graham. (2003). Isolation of High Molecular Weight DNA Suitable for the Construction of Genomic Libraries. Humana Press eBooks. 4. 221–234. 1 indexed citations
16.
Ballance, D. J., et al.. (1992). A hybrid protein of urokinase growth‐factor domain and plasminogen‐activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor. European Journal of Biochemistry. 207(1). 177–183. 7 indexed citations
17.
Sleep, Darrell, Graham Belfield, D. J. Ballance, et al.. (1991). Saccharomyces Cerevisiae Strains that Overexpress Heterologous Proteins. Nature Biotechnology. 9(2). 183–187. 60 indexed citations
18.
King, Linda A., et al.. (1991). Secretion of single-chain urokinase-type plasminogen activator from insect cells. Gene. 106(2). 151–157. 4 indexed citations
19.
Steven, John, et al.. (1991). Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae. European Journal of Biochemistry. 196(2). 431–438. 18 indexed citations
20.
Baker, Betty S., John Steven, & Jamshed R. Tata. (1985). Vitellogenin genes and their products in closely and distantly related species of Xenopus. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 82(3). 497–505. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald P. Donovan Breakdown of academic impact, for papers by Andrea L. J. Marschall Breakdown of academic impact, for papers by Susanne Kubetzko Breakdown of academic impact, for papers by Mahdi Habibi‐Anbouhi Breakdown of academic impact, for papers by Cécile Artaud Breakdown of academic impact, for papers by Amélie Robert Breakdown of academic impact, for papers by Tove Eriksson Breakdown of academic impact, for papers by C. R. Bebbington Breakdown of academic impact, for papers by Teodor‐D. Brumeanu Breakdown of academic impact, for papers by Karen Silence
Rankless by CCL
2026